LRRK2 c.2803T>G ;(p.S935A)

Variant ID: 12-40687460-T-G

NM_198578.3(LRRK2):c.2803T>G;(p.S935A)

This variant was identified in 14 publications

View GRCh38 version.




Publications:


The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.

The Journal Of Cell Biology
Stormo, Adrienne E D AED; Shavarebi, Farbod F; FitzGibbon, Molly M; Earley, Elizabeth M EM; Ahrendt, Hannah H; Lum, Lotus S LS; Verschueren, Erik E; Swaney, Danielle L DL; Skibinski, Gaia G; Ravisankar, Abinaya A; van Haren, Jeffrey J; Davis, Emily J EJ; Johnson, Jeffrey R JR; Von Dollen, John J; Balen, Carson C; Porath, Jacob J; Crosio, Claudia C; Mirescu, Christian C; Iaccarino, Ciro C; Dauer, William T WT; Nichols, R Jeremy RJ; Wittmann, Torsten T; Cox, Timothy C TC; Finkbeiner, Steve S; Krogan, Nevan J NJ; Oakes, Scott A SA; Hiniker, Annie A
Publication Date: 2022-04-04

Variant appearance in text: LRRK2: Ser935Ala
PubMed Link: 35266954
Variant Present in the following documents:
  • Main text
  • JCB_202010065.pdf
View BVdb publication page



Physiological and pathological functions of LRRK2: implications from substrate proteins.

Neuronal Signaling
Araki, Miho M; Ito, Genta G; Tomita, Taisuke T
Publication Date: 2018-12

Variant appearance in text: LRRK2: S935A
PubMed Link: 32714591
Variant Present in the following documents:
  • Main text
  • ns-02-ns20180005.pdf
View BVdb publication page



Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine-Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme-Linked Immunosorbent Assay-Based Method.

Movement Disorders : Official Journal Of The Movement Disorder Society
Melachroinou, Katerina K; Kang, Min Suk MS; Liong, Christopher C; Narayan, Sushma S; Levers, Najah N; Joshi, Neal N; Kopil, Katie K; Hutten, Samantha J SJ; Baptista, Marco A S MAS; Padmanabhan, Shalini S; Kang, Un Jung UJ; Stefanis, Leonidas L; Alcalay, Roy N RN; Rideout, Hardy J HJ
Publication Date: 2020-11

Variant appearance in text: LRRK2: S935A
PubMed Link: 32652692
Variant Present in the following documents:
  • Main text
View BVdb publication page



LRRK2 Phosphorylation, More Than an Epiphenomenon.

Frontiers In Neuroscience
Marchand, Antoine A; Drouyer, Matthieu M; Sarchione, Alessia A; Chartier-Harlin, Marie-Christine MC; Taymans, Jean-Marc JM
Publication Date: 2020

Variant appearance in text: LRRK2: S935A
PubMed Link: 32612495
Variant Present in the following documents:
  • Main text
  • fnins-14-00527.pdf
View BVdb publication page



LRRK2 Is Recruited to Phagosomes and Co-recruits RAB8 and RAB10 in Human Pluripotent Stem Cell-Derived Macrophages.

Stem Cell Reports
Lee, Heyne H; Flynn, Rowan R; Sharma, Ishta I; Haberman, Emma E; Carling, Phillippa J PJ; Nicholls, Francesca J FJ; Stegmann, Monika M; Vowles, Jane J; Haenseler, Walther W; Wade-Martins, Richard R; James, William S WS; Cowley, Sally A SA
Publication Date: 2020-05-12

Variant appearance in text: LRRK2: S935A
PubMed Link: 32359446
Variant Present in the following documents:
  • Main text
View BVdb publication page



Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization.

Molecular Neurobiology
De Wit, T T; Baekelandt, V V; Lobbestael, E E
Publication Date: 2019-08

Variant appearance in text: LRRK2: S935A
PubMed Link: 30592011
Variant Present in the following documents:
  • Main text
  • 12035_2018_Article_1449.pdf
View BVdb publication page



Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice.

Neurobiology Of Disease
Zhao, Ye Y; Keshiya, Shikara S; Atashrazm, Farzaneh F; Gao, Jianqun J; Ittner, Lars M LM; Alessi, Dario R DR; Halliday, Glenda M GM; Fu, Yuhong Y; Dzamko, Nicolas N
Publication Date: 2018-12

Variant appearance in text: LRRK2: S935A
PubMed Link: 30194047
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation.

Scientific Reports
Lobbestael, E E; Civiero, L L; De Wit, T T; Taymans, J-M JM; Greggio, E E; Baekelandt, V V
Publication Date: 2016-09-23

Variant appearance in text: LRRK2: S935A
PubMed Link: 27658356
Variant Present in the following documents:
  • Main text
  • srep33897.pdf
View BVdb publication page



Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors.

The Biochemical Journal
Ito, Genta G; Katsemonova, Kristina K; Tonelli, Francesca F; Lis, Pawel P; Baptista, Marco A S MA; Shpiro, Natalia N; Duddy, Graham G; Wilson, Steve S; Ho, Philip Wing-Lok PW; Ho, Shu-Leong SL; Reith, Alastair D AD; Alessi, Dario R DR
Publication Date: 2016-09-01

Variant appearance in text: LRRK2: S935A
PubMed Link: 27474410
Variant Present in the following documents:
  • Main text
  • bj4732671.pdf
View BVdb publication page



14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.

Human Molecular Genetics
Lavalley, Nicholas J NJ; Slone, Sunny R SR; Ding, Huiping H; West, Andrew B AB; Yacoubian, Talene A TA
Publication Date: 2016-01-01

Variant appearance in text: LRRK2: S935A
PubMed Link: 26546614
Variant Present in the following documents:
  • Main text
View BVdb publication page



Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7.

Nature Communications
Chia, Ruth R; Haddock, Sara S; Beilina, Alexandra A; Rudenko, Iakov N IN; Mamais, Adamantios A; Kaganovich, Alice A; Li, Yan Y; Kumaran, Ravindran R; Nalls, Michael A MA; Cookson, Mark R MR
Publication Date: 2014-12-15

Variant appearance in text: LRRK2: S935A
PubMed Link: 25500533
Variant Present in the following documents:
  • nihms641836.pdf
View BVdb publication page



Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation.

Plos One
Hermanson, Spencer B SB; Carlson, Coby B CB; Riddle, Steven M SM; Zhao, Jing J; Vogel, Kurt W KW; Nichols, R Jeremy RJ; Bi, Kun K
Publication Date: 2012

Variant appearance in text: LRRK2: Ser935Ala
PubMed Link: 22952710
Variant Present in the following documents:
  • Main text
  • pone.0043580.pdf
View BVdb publication page



Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease.

Plos One
Li, Xianting X; Wang, Qing Jun QJ; Pan, Nina N; Lee, Sangkyu S; Zhao, Yingming Y; Chait, Brian T BT; Yue, Zhenyu Z
Publication Date: 2011-03-01

Variant appearance in text: LRRK2: S935A
PubMed Link: 21390248
Variant Present in the following documents:
  • Main text
View BVdb publication page



14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.

The Biochemical Journal
Nichols, R Jeremy RJ; Dzamko, Nicolas N; Morrice, Nicholas A NA; Campbell, David G DG; Deak, Maria M; Ordureau, Alban A; Macartney, Thomas T; Tong, Youren Y; Shen, Jie J; Prescott, Alan R AR; Alessi, Dario R DR
Publication Date: 2010-09-15

Variant appearance in text: LRRK2: S935A
PubMed Link: 20642453
Variant Present in the following documents:
  • Main text
  • bj4300393.pdf
View BVdb publication page